Pfizer Inc. announced Monday it has secured exclusive global rights, excluding China, to 3SBio Inc.'s bispecific antibody ...

Pfizer just penned a $6 billion licensing deal with China's 3SBio to develop and commercialize a cancer drug, SSGJ-707. The ...

Pfizer has signed a licensing agreement worth up to $6 billion with Chinese pharmaceutical products developer 3SBio Inc for ...

Countries can’t agree on how to share and compensate for pathogen data Global pandemic treaty nears adoption, but key ...

At a recent gathering, experts in the Swiss biotech and pharma sector underscored the power of international alliances.

Metro Loft and David Werner’s secured $720 million of construction financing to execute New York City’s largest office-resi ...